Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4gn8 | ASO | Regucalcin | 3.1.1.17 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4gn8 | ASO | Regucalcin | 3.1.1.17 | 1.000 | |
4gnc | ASO | Regucalcin | 3.1.1.17 | 0.466 | |
4i6a | HMG | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.88 | 0.450 | |
2jdt | I5S | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
1f8w | FAD | NADH peroxidase | 1.11.1.1 | 0.444 | |
4n3c | UD1 | UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit | / | 0.444 | |
5c1m | CLR | Mu-type opioid receptor | / | 0.441 |